Biocryst Pharmaceuticals (BCRX) Other Working Capital Changes (2010 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Other Working Capital Changes came in at -$749000.0 in Q1 2026, down 78.76% on a QoQ basis from -$419000.0 in Q4 2023.
Biocryst Pharmaceuticals (BCRX) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 7 years of Other Working Capital Changes data on file, last reported at -$749000.0 in Q1 2026.
- Quarterly Other Working Capital Changes changed N/A year-over-year to -$749000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$749000.0 (changed N/A YoY) and the FY2023 annual result came in at -$1.2 million, down 1028.44% from the prior year.
- Other Working Capital Changes eased to -$749000.0 in Q1 2026, from -$419000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $6.0 million in Q3 2023 to a low of -$3.5 million in Q1 2026.
- A 5-year average of $690529.4 and a median of $82000.0 in 2022 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 413.51% in 2023, down 1041.26% in 2023.
- Tracing BCRX's Other Working Capital Changes over 3 years: stood at -$438000.0 in 2022, then climbed by 4.34% to -$419000.0 in 2023, then tumbled by 78.76% to -$749000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$749000.0 (Q1 2026), -$419000.0 (Q4 2023), and -$1.3 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.45 Bn | 2.10 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.43 Mn |
| Jun 30, 2026 | -4.43 Mn |
| Jun 30, 2026 | -4.43 Mn |
| Mar 31, 2026 | -3.53 Mn |
| Mar 31, 2026 | -3.53 Mn |
| Mar 31, 2026 | -3.53 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Sep 30, 2025 | 5.92 Mn |
| Sep 30, 2025 | 5.92 Mn |
| Sep 30, 2025 | 5.92 Mn |
| Jun 30, 2025 | -160,000.00 |
| Jun 30, 2025 | -160,000.00 |
| Jun 30, 2025 | -160,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Dec 31, 2024 | -574,000.00 |
| Dec 31, 2024 | -574,000.00 |